Periodic Reporting for period 1 - Mendi Neurofeedback (The world’s most powerful brain training device for home use.)
Período documentado: 2019-10-01 hasta 2020-03-31
Mendi Innovations AB is a cutting-edge European neurofeedback company located in Stockholm, Sweden. Neurofeedback methods use brain training techniques coupled with direct imaging of neural activity to improve brain function, but current approaches are limited to expensive clinics, or low accuracy consumer products. Co-founders Sammy Saldjoghi and Rickard Eklöf started Mendi in 2018 to bring the most advanced neurofeedback imaging techniques and training methods, used in neurofeedback clinics around the world, into the consumer market.
The overall objectives are to improve mental health and well-being.
Scope: Activities will include 5 key areas:
· Perform a close customer consultation to determine the full requirements for our devices.
· Evaluate our market position and go-to-market strategy and update partnerships and business plans.
· Deepen our full value chain understanding to refine our business and pricing models.
· Protect our commercial position through patent(s) for the most valuable application areas.
· Plan and secure finances for phase 2 activities and budgets, market introduction and eventual scaling up.
Work Plan:
Validate commercial/market feasibility of Mendi Gen2 and Platform/B2B/B2G approach.
· Perform detailed market study and determine target market data, dynamics, stakeholders and approaches;
· Perform deep customer consultation, map requirements to system specifications, update technical roadmap;
· Demonstrate additional prototypes to meet specific market vertical requirements;
· Analyse the need for and implement further/stronger IPR protection (patents and other methods);
· Build partnerships to support phase 2 commercial activity: prototype production trials, commercial.
Validate economic/financial feasibility of Mendi Gen2 and Platform/B2B/B2G approach.
· Further analyse the target markets to confirm the best market entry verticals;
· Deepen understanding of mental HealthTech, performance, and wellness value chains and cost breakdown;
· Investigate the commercial potential and impact of system features and roll-out strategies;
· Update our financial plan to ensure the financial, personnel, and other resources are in place for market entry, including the activities, resources and budget for market validation (phase 2)
Deliverable: A feasibility study report including analysis of market position, target verticals and market potential, commercial protection, commercial potential of system features, and optimum go-to-market strategy
A larger reach requires expansion into new verticals, products, B2G/B. This is currently hampered by long lead times and an insufficient knowledge of the markets. Although we cannot evaluate a positive feasibility to move into B2G/B at this time, we have taken steps to facilitate this: Hiring fNIRs neurofeedback researchers, preparing our Gen 2 device for data integration with clinical systems through an open data API, securing letters of support and intent for small scale clinical trials. A major near-term effort in this direction will however require more funding than we can source ourselves (through Gen 1 bootstrapping or private funding). However, it will open the possibility of 1-2 orders of magnitude improvement in revenue and societal impact. Again, this will push the state of the art, which is Mendi, even further forwards.